Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Neuroleptic malignant syndrome Rampertaap MPSouth Med J 1986[Mar]; 79 (3): 331-6The neuroleptic malignant syndrome (NMS) is a rare but potentially lethal disorder associated with the administration of neuroleptic agents. This syndrome may be underdiagnosed because it is poorly understood and often unrecognized. It affects all age groups and has a 20% mortality. Presenting features include extrapyramidal symptoms, altered mental consciousness, autonomic dysfunction, and hyperthermia. The underlying explanation for these manifestations is a disturbance of the dopaminergic system within the basal ganglia and hypothalamus. Dantrolene (Dantrium), amantadine (Symmetrel), and bromocriptine mesylate (Parlodel) have been efficacious in conjunction with supportive therapy. I report three cases successfully treated with bromocriptine and supportive therapy.|Adolescent[MESH]|Adult[MESH]|Benztropine/adverse effects/analogs & derivatives[MESH]|Bromocriptine/therapeutic use[MESH]|Catatonia/diagnosis[MESH]|Child[MESH]|Child, Preschool[MESH]|Diagnosis, Differential[MESH]|Female[MESH]|Fluphenazine/adverse effects/analogs & derivatives[MESH]|Haloperidol/adverse effects[MESH]|Heat Exhaustion/diagnosis[MESH]|Humans[MESH]|Male[MESH]|Malignant Hyperthermia/diagnosis[MESH]|Middle Aged[MESH]|Neuroleptic Malignant Syndrome/*diagnosis/drug therapy[MESH]|Psychotic Disorders/drug therapy[MESH]|Schizophrenia, Paranoid/drug therapy[MESH]|Time Factors[MESH] |